Device / Technology News

RSS

Second Sight's Argus II Retinal Prosthesis System selected for Forfait Innovation reimbursement

Second Sight Medical Products Inc. announces today that the Argus II Retinal Prosthesis System, the world’s first approved device intended to restore some functional vision for people suffering from blindness due to outer retinal degenerations, has become the first recipient of the French Government national healthcare reimbursement program entitled ‘Forfait Innovation’.

1 Apr 2014

Warwick researchers develop 2D hand gesture recognition technology that works in natural light

Mobile phones could soon be turned into hand gesture recognition devices following a technological breakthrough.

1 Apr 2014

Proprietary Novozymes technology used in GlaxoSmithKline’s new diabetes treatment

Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.

1 Apr 2014

NextGen Healthcare Information Systems issues statement following Senate vote to patch SGR, delay ICD-10

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, today issued a statement following the Senate vote to patch the Sustainable Growth Rate ("SGR" or "Doc Fix") and delay ICD-10 for another year to October 2015.

1 Apr 2014

Trinean, Sony DADC sign manufacturing and supply agreement to develop microfluidic disposables

Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced that it entered into a manufacturing and supply agreement with Sony DADC for the production of microfluidic disposables fit for storage and micro-cuvette analysis of droplet-sized biological samples.

1 Apr 2014

Bruker introduces multiscale high-resolution X-ray nanotomograph, Skyscan 2211

At Analytica 2014, Bruker today introduced the SkyScan TM 2211, a new high-resolution X-ray nano-CT (computed tomography) system with the widest available range of object sizes and spatial resolutions.

1 Apr 2014

Wounds may heal more quickly if exposed to low-intensity vibration, say researchers

Wounds may heal more quickly if exposed to low-intensity vibration, report researchers at the University of Illinois at Chicago.

1 Apr 2014

GIN and Sigolis merge to create new company, Ginolis Oy

Global Innovation Network Oy (GIN) and Sigolis AB today announced a merger of the two companies. The new company, named Ginolis Oy, provides an innovative one-stop solution for the development and manufacturing of in vitro diagnostic (IVD) disposable products.

1 Apr 2014

Researchers discover anesthetic technique to reduce patients' blood pressure

Researchers at the University of Adelaide have discovered that a commonly used anesthetic technique to reduce the blood pressure of patients undergoing surgery could increase the risk of starving the brain of oxygen.

1 Apr 2014

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Tamiflu is one of the few available treatments for those who come down with the flu. But the virus quickly develops resistance; multiplying at a rate of several generations a day, these tiny pathogens rapidly accumulate genetic mutations. Because of this, they have a good chance of developing counterattacks to the antiviral. How can these infinitesimal variations be identified within the immensity of the virus' genetic code? EPFL researchers have created a computer tool that can shed light on the flu virus' formidable adaptability.

1 Apr 2014

Sodium pump plays vital role in nerve impulses, heartbeats and muscular contraction

A study in The Journal of General Physiology provides new evidence that the ubiquitous sodium pump is more complex-and more versatile-than we thought.

1 Apr 2014

Machaon Diagnostics' aHUS Genetic Panel confirms atypical Hemolytic Uremic Syndrome in 48 hours

Machaon Diagnostics today announced the availability of its "aHUS Genetic Panel" (patent pending) to genetically confirm atypical Hemolytic Uremic Syndrome (aHUS) with a turnaround time of 48 hours. The 48 hour timeframe is a dramatic advancement over other approaches which offer results in 4-13 weeks.

1 Apr 2014

New device simulates gastro-intestinal tract

A breakthrough in drug testing developed by a University of Huddersfield lecturer could lead to cheaper, more effective medicines. Dr Hamid Merchant is a member of the team that has created a device which accurately simulates the gastro-intestinal tract and how it absorbs medication.

1 Apr 2014

Mobile phones with tobacco screening guidelines offer cessation counseling

Smartphones and tablets may hold the key to getting more clinicians to screen patients for tobacco use and advise smokers on how to quit. Even though tobacco use is the leading cause of preventable disease and death in the U.S., clinicians often don't ask about smoking during patient exams.

1 Apr 2014

Full-field digital mammography associated with lower recall and biopsy rates, says study

Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study published online in the journal Radiology.

1 Apr 2014

BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma.

31 Mar 2014

Cellulose nanofiber paper filter removes virus particles with high efficiency

Researchers at the Division of Nanotechnology and Functional Materials, Uppsala University have developed a paper filter, which can remove virus particles with the efficiency matching that of the best industrial virus filters. The paper filter consists of 100 percent high purity cellulose nanofibers, directly derived from nature.

31 Mar 2014

ZO Skin Health, Cellogique announce launch of ZO Medical products in Middle East

ZO Skin Health, Inc. and Cellogique Corporation are pleased to announce the launch of the ZO Medical product line to the Middle East region at The Dubai World Dermatology & Laser Conference & Exhibition – Dubai Derma, April 8-10, 2014.

31 Mar 2014

Venaxis files 510(k) premarket submission with FDA for APPY1 Test

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.

31 Mar 2014

New FDA Roadmap App helps sponsors improve clinical research

The new FDA Roadmap App from PHT Corporation helps sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials released by the FDA with their Clinical Outcome Assessment Qualification Program.

31 Mar 2014

Device / Technology News

Second Sight's Argus II Retinal Prosthesis System selected for Forfait Innovation reimbursement

Warwick researchers develop 2D hand gesture recognition technology that works in natural light

Proprietary Novozymes technology used in GlaxoSmithKline’s new diabetes treatment

NextGen Healthcare Information Systems issues statement following Senate vote to patch SGR, delay ICD-10

Trinean, Sony DADC sign manufacturing and supply agreement to develop microfluidic disposables

Bruker introduces multiscale high-resolution X-ray nanotomograph, Skyscan 2211

Wounds may heal more quickly if exposed to low-intensity vibration, say researchers

GIN and Sigolis merge to create new company, Ginolis Oy

Researchers discover anesthetic technique to reduce patients' blood pressure

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Sodium pump plays vital role in nerve impulses, heartbeats and muscular contraction

Machaon Diagnostics' aHUS Genetic Panel confirms atypical Hemolytic Uremic Syndrome in 48 hours

New device simulates gastro-intestinal tract

Mobile phones with tobacco screening guidelines offer cessation counseling

Full-field digital mammography associated with lower recall and biopsy rates, says study

BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study

Cellulose nanofiber paper filter removes virus particles with high efficiency

ZO Skin Health, Cellogique announce launch of ZO Medical products in Middle East

Venaxis files 510(k) premarket submission with FDA for APPY1 Test

New FDA Roadmap App helps sponsors improve clinical research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News